U.S. markets closed

Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS)

Shanghai - Shanghai Delayed Price. Currency in CNY
Add to watchlist
23.22+0.44 (+1.93%)
At close: 03:00PM CST

Nanjing Well Pharmaceutical Group Co.,Ltd.

Building 5, 64 Suning Avenue
Xuzhuang Software Park Xuanwu District
Nanjing 210042
86 25 8573 2322

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees615

Key Executives

NameTitlePayExercisedYear Born
Mr. Renrong WuChairman & CEON/AN/A1963
Mr. Qunsong TangSec. of the Board of Directors & CFON/AN/A1967
Mr. Zhengsong GaoDirector, VP & Chief EngineerN/AN/A1965
Mr. Xinguo ChenDirector & VPN/AN/A1968
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.


Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical auxiliary materials in China. Its pharmaceutical materials include excipients for injectables and non-injectables. The company also provides synthetic base oils, such as hydraulic fluids, lubricity additives for metals, metal quenching, base fluids and lubricity additives, synthetic base for compress lubricants, synthetic base oil for gear, base oil of chain lubricants, base stock of engine oil, base stock of heat transfer oil, and base oil of grease; and other products, including painting and coating, textile chemicals, field chemicals, and low foam metal cleaners. It also exports its products to Europe, the United States, Southeast Asia, and internationally. The company was formerly known as Nanjing Well Pharmaceutical Co.,Ltd. and changed its name to Nanjing Well Pharmaceutical Group Co.,Ltd. in April 2020. The company was founded in 2000 and is based in Nanjing, China.

Corporate Governance

Nanjing Well Pharmaceutical Group Co.,Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.